US › Healthcare

Achieve Life Sciences Inc (ACHV)

US · Healthcare · Biotechnology

$6.47+2.37%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$0
Net profit
$-10.2M
Profit YoY
+20.7%
EPS
$-0.19
EPS estimate
$-0.30

EPS came in at -0.19 against a street estimate of -0.30 — a beat of 36.7%.

Key statistics

Market cap
$659.1M
Forward P/E
35.3
P/B
61.48
Book value
$0.20
EPS (TTM)
$-1.07
52-week high
$7.11
52-week low
$2.37
50-day MA
$5.73
200-day MA
$4.77
Beta
2.23

Analyst view

Analysts rate Achieve Life Sciences Inc a strong buy (8 buy, 0 hold, 0 sell out of 8) with an average price target of $13.80.

Shareholding

Insiders
0.93%
Institutions
66.60%

Largest institutional holders

FundStake
Franklin Resources Inc4.26%
Propel Bio Management LLC3.69%
Vanguard Capital Management, LLC2.15%
Simplify Asset Management Inc.1.40%
Millennium Management LLC1.05%
Marshall Wace Asset Management Ltd0.99%
LPL Financial Corp0.71%
Nantahala Capital Management, LLC0.63%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Achieve Life Sciences Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.